Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.
2.

Disease-associated XMRV sequences are consistent with laboratory contamination.

Hué S, Gray ER, Gall A, Katzourakis A, Tan CP, Houldcroft CJ, McLaren S, Pillay D, Futreal A, Garson JA, Pybus OG, Kellam P, Towers GJ.

Retrovirology. 2010 Dec 20;7(1):111. doi: 10.1186/1742-4690-7-111.

3.

Analysis of single-nucleotide polymorphisms in patient-derived retrovirus integration sites reveals contamination from cell lines acutely infected by xenotropic murine leukemia virus-related virus.

Rusmevichientong A, Das Gupta J, Elias PS, Silverman RH, Chow SA.

J Virol. 2011 Dec;85(23):12830-4. doi: 10.1128/JVI.05624-11. Epub 2011 Sep 21.

4.

Mouse DNA contamination in human tissue tested for XMRV.

Robinson MJ, Erlwein OW, Kaye S, Weber J, Cingoz O, Patel A, Walker MM, Kim WJ, Uiprasertkul M, Coffin JM, McClure MO.

Retrovirology. 2010 Dec 20;7:108. doi: 10.1186/1742-4690-7-108.

5.

Recombinant origin of the retrovirus XMRV.

Paprotka T, Delviks-Frankenberry KA, Cingöz O, Martinez A, Kung HJ, Tepper CG, Hu WS, Fivash MJ Jr, Coffin JM, Pathak VK.

Science. 2011 Jul 1;333(6038):97-101. doi: 10.1126/science.1205292. Epub 2011 May 31.

6.

Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer.

Kim S, Kim N, Dong B, Boren D, Lee SA, Das Gupta J, Gaughan C, Klein EA, Lee C, Silverman RH, Chow SA.

J Virol. 2008 Oct;82(20):9964-77. doi: 10.1128/JVI.01299-08. Epub 2008 Aug 6.

7.

No evidence of XMRV in prostate cancer cohorts in the Midwestern United States.

Sakuma T, Hué S, Squillace KA, Tonne JM, Blackburn PR, Ohmine S, Thatava T, Towers GJ, Ikeda Y.

Retrovirology. 2011 Mar 29;8:23. doi: 10.1186/1742-4690-8-23.

8.

XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors.

Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR.

Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16351-6. doi: 10.1073/pnas.0906922106. Epub 2009 Sep 8. Retraction in: Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR. Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12270.

9.

XMRV: a new virus in prostate cancer?

Aloia AL, Sfanos KS, Isaacs WB, Zheng Q, Maldarelli F, De Marzo AM, Rein A.

Cancer Res. 2010 Dec 15;70(24):10028-33. doi: 10.1158/0008-5472.CAN-10-2837. Epub 2010 Oct 21.

10.

No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe.

Stieler K, Schindler S, Schlomm T, Hohn O, Bannert N, Simon R, Minner S, Schindler M, Fischer N.

PLoS One. 2011;6(10):e25592. doi: 10.1371/journal.pone.0025592. Epub 2011 Oct 12.

11.

Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences.

Oakes B, Tai AK, Cingöz O, Henefield MH, Levine S, Coffin JM, Huber BT.

Retrovirology. 2010 Dec 20;7:109. doi: 10.1186/1742-4690-7-109.

12.

XMRV as a human pathogen?

Wainberg MA, Jeang KT.

Cell Host Microbe. 2011 Apr 21;9(4):260-2. doi: 10.1016/j.chom.2011.04.001.

13.

No association of xenotropic murine leukemia virus-related viruses with prostate cancer.

Switzer WM, Jia H, Zheng H, Tang S, Heneine W.

PLoS One. 2011 May 4;6(5):e19065. doi: 10.1371/journal.pone.0019065.

14.

Absence of XMRV and closely related viruses in primary prostate cancer tissues used to derive the XMRV-infected cell line 22Rv1.

Das Gupta J, Luk KC, Tang N, Gaughan C, Klein EA, Kandel ES, Hackett J Jr, Silverman RH.

PLoS One. 2012;7(5):e36072. doi: 10.1371/journal.pone.0036072. Epub 2012 May 16.

15.

The left half of the XMRV retrovirus is present in an endogenous retrovirus of NIH/3T3 Swiss mouse cells.

Mendoza R, Vaughan AE, Miller AD.

J Virol. 2011 Sep;85(17):9247-8. doi: 10.1128/JVI.05137-11. Epub 2011 Jun 22.

16.

No association between XMRV or related gammaretroviruses in Australian prostate cancer patients.

Rezaei SD, Hearps AC, Mills J, Pedersen J, Tachedjian G.

Virol J. 2013 Jan 10;10:20. doi: 10.1186/1743-422X-10-20.

17.

In-depth investigation of archival and prospectively collected samples reveals no evidence for XMRV infection in prostate cancer.

Lee D, Das Gupta J, Gaughan C, Steffen I, Tang N, Luk KC, Qiu X, Urisman A, Fischer N, Molinaro R, Broz M, Schochetman G, Klein EA, Ganem D, Derisi JL, Simmons G, Hackett J Jr, Silverman RH, Chiu CY.

PLoS One. 2012;7(9):e44954. doi: 10.1371/journal.pone.0044954. Epub 2012 Sep 18.

18.

Multiple sources of contamination in samples from patients reported to have XMRV infection.

Kearney MF, Spindler J, Wiegand A, Shao W, Anderson EM, Maldarelli F, Ruscetti FW, Mellors JW, Hughes SH, Le Grice SF, Coffin JM.

PLoS One. 2012;7(2):e30889. doi: 10.1371/journal.pone.0030889. Epub 2012 Feb 20.

19.

Recombinant origin, contamination, and de-discovery of XMRV.

Delviks-Frankenberry K, Cingöz O, Coffin JM, Pathak VK.

Curr Opin Virol. 2012 Aug;2(4):499-507. doi: 10.1016/j.coviro.2012.06.009. Epub 2012 Jul 19. Review.

20.

Detection of Xenotropic murine leukemia virus-related virus in prostate biopsy samples.

Baig FA, Mirza T, Khanani R, Khan S.

J Coll Physicians Surg Pak. 2014 Sep;24(9):636-9. doi: 09.2014/JCPSP.636639.

PMID:
25233966

Supplemental Content

Support Center